Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” ; volume:40 ; number:10 ; day:26 ; month:9 ; year:2022 ; pages:1011-1012 ; date:10.2022
PharmacoEconomics ; 40, Heft 10 (26.9.2022), 1011-1012, 10.2022
- Creator
-
Giannelos, Nikolaos
Nishimwe, Marie Libérée
Lecrenier, Nicolas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40273-022-01184-0
- URN
-
urn:nbn:de:101:1-2022122820595495250318
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giannelos, Nikolaos
- Nishimwe, Marie Libérée
- Lecrenier, Nicolas
- SpringerLink (Online service)
Other Objects (12)
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
COVID-19 Vaccination Mandates and Vaccine Uptake
Vaccine/Vaccination Hesitancy: Challenging Science and Society
Vaccine-Skeptic Physicians and COVID-19 Vaccination Rates
Vaccine-skeptic physicians and COVID-19 vaccination rates
Modelling vaccination schedules for a cancer immunoprevention vaccine
Towards understanding vaccine hesitancy and vaccination refusal in Austria
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
COVID-19 Vaccination Mandates and Vaccine Uptake
Vaccine/Vaccination Hesitancy: Challenging Science and Society
Vaccine-Skeptic Physicians and COVID-19 Vaccination Rates
Vaccine-skeptic physicians and COVID-19 vaccination rates
Modelling vaccination schedules for a cancer immunoprevention vaccine
Towards understanding vaccine hesitancy and vaccination refusal in Austria
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
COVID-19 Vaccination Mandates and Vaccine Uptake
Vaccine/Vaccination Hesitancy: Challenging Science and Society
Vaccine-Skeptic Physicians and COVID-19 Vaccination Rates
Vaccine-skeptic physicians and COVID-19 vaccination rates
Modelling vaccination schedules for a cancer immunoprevention vaccine
Towards understanding vaccine hesitancy and vaccination refusal in Austria
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine